Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Chemical analysis
Reexamination Certificate
2007-04-13
2010-06-29
Steadman, David J (Department: 1656)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Chemical analysis
C435S018000, C435S004000, C435S005000, C435S007210, C435S007220, C435S007320
Reexamination Certificate
active
07747395
ABSTRACT:
The present invention provides the three-dimensional structure of human mitochondrialHomo sapienspeptide deformylase (HsPDF) protein, and HsPDF complexed to a binding compound, such as a PDF inhibitor. This crystallographic information will aid in the identification and development of novel binding compounds of HsPDF and other PDF family members which have anti-bacterial, anti-viral, anti-parasitical, anti-inflammatory, and/or anti-cancer activity.
REFERENCES:
patent: 2008/0124808 (2008-05-01), Rodgers et al.
Lee et al., J. Clin. Invest. 114:1107-1116, 2004.
Lee et al., “A new human peptide deformylase inhibitable by actinonin”, Biochem. Biophys. Res. Comm. 312:309-315, 2003.
Altschul et al., Basic local alignment search tool. J Mol Biol. Oct. 5, 1990;215(3):403-10.
Antczak et al., High-throughput identification of inhibitors of human mitochondrial peptide deformylase. J Biomol. Screen. 2007;12(4):521-35.
Apfel et al., Peptide deformylase as an antibacterial drug target: target validation and resistance development. Antimicrob Agents Chemother. Apr. 2001;45(4):1058-64.
Bailey et al., TheCCP4Suite: Programs for Protein Crystallography. Acta Crystallogr D. 1994;50:760-63.
Balakrishnon et al., Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium. J Biol Chem. Jun. 16, 2006;281(24):16691-9. Epub Mar. 24, 2006.
Baldwin et al., Crystal structure of type II peptide deformylase from Staphylococcus aureus. J Biol Chem. Aug. 23, 2002;277(34):31163-71. Epub Jun. 4, 2002.
Bartlett et al., Molecular Recognition in Chemical and Biological Problems, Special Pub., Royal Chem Soc. 1989;78:182-96.
Becker et al., Iron center, substrate recognition and mechanism of peptide deformylase. Nat Struct Biol. Dec. 1998;5(12):1053-8.
Becker et al., Structure of peptide deformylase and identification of the substrate binding site. J Biol Chem. May 8, 1998;273(19):11413-6.
Bingel-Erlenmeyer et al., A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing. Nature. Mar. 6, 2008;452(7183):108-11. Epub Feb. 20, 2008.
Böhm, The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des. Feb. 1992;6(1):61-78.
Bonnet et al., A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. Jan. 2007;11(1):37-51.
Boularot et al., Discovery and refinement of a new structural class of potent peptide deformylase inhibitors. J Med Chem. Jan. 11, 2007;50(1):10-20.
Brünger et al., Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. Sep. 1, 1998;54(Pt 5):905-21.
Chan et al., Crystal structure of theEscherichia colipeptide deformylase. Biochemistry. Nov. 11, 1997;36(45):13904-9.
Chen et al., Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor. Biochemistry. Feb. 15, 2000;39(6):1256-62.
Clamp et al., The Jalview Java alignment editor. Bioinformatics. Feb. 12, 2004;20(3):426-7. Epub Jan. 22, 2004.
Clements et al., Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother. Feb. 2001;45(2):563-70.
Cohen et al., Molecular modeling software and methods for medicinal chemistry. J Med Chem. Mar. 1990;33(3):883-94.
Don et al., Mitochondria as cancer drug targets. Trends Mol Med. Aug. 2004;10(8):372-8.
Escobar-Alvarez et al., Structure and activity of human mitochondrial peptide deformylase, a novel cancer target. J Mol Biol. Apr. 17, 2009;387(5):1211-28. Epub Feb. 21, 2009.
Fearnley et al., Two overlapping genes in bovine mitochondrial DNA encode membrane components of ATP synthase. EMBO J. Aug. 1986;5(8):2003-8.
Fieulaine et al., The crystal structure of mitochondrial (Type 1A) peptide deformylase provides clear guidelines for the design of inhibitors specific for the bacterial forms. J Biol Chem. Dec. 23, 2005;280(51):42315-24. Epub Sep. 28, 2005.
Giglione et al., Control of protein life-span by N-terminal methionine excision. EMBO J. Jan. 2, 2003;22(1):13-23.
Giglione et al., Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. EMBO J. Nov. 1, 2000;19(21):5916-29.
Giglione et al., Organellar peptide deformylases: universality of the N-terminal methionine cleavage mechanism. Trends Plant Sci. Dec. 2001;6(12):566-72.
Golovchenko et al., Analysis of pH-dependent protein interactions with gel filtration medium. J Chromatogr. Feb. 7, 1992;591(1-2):121-8.
Good et al., Hydrogen ion buffers for biological research. Biochemistry. Feb. 1966;5(2):467-77.
Goodford, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J Med Chem. Jul. 1985;28(7):849-57.
Goodsell et al., Automated docking of substrates to proteins by simulated annealing. Proteins. 1990;8(3):195-202.
Grant et al., Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase. Bioorg Chem. Aug. 2001;29(4):211-22.
Grujic et al., Actinonin induces apoptosis in U937 leukemia cells. Cancer Lett. Jun. 8, 2005;223(2):211-8. Epub Dec. 13, 2004.
Guilloteau et al., The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents. J Mol Biol. Jul. 26, 2002;320(5):951-62.
Harris et al., Co-crystallization ofStaphylococcus aureuspeptide deformylase (PDF) with potent inhibitors. Acta Crystallogr D Biol Crystallogr. Dec. 2002;58(Pt 12):2153-6. Epub Nov. 23, 2002.
Howard et al., A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening. J Med Chem. Dec. 30, 2004;47(27):6669-72.
Jain et al., Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents. Curr Med Chem. 2005;12(14):1607-21.
Jenkins et al., Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci U S A. Jun. 20, 1995;92(13):6057-61.
Jones et al., Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates. J Antimicrob Chemother. May 2004;53(5):804-7. Epub Mar. 31, 2004.
Kierzek et al., Models of protein crystal growth. Biophys Chem. Jun. 15, 2001;91(1):1-20.
Kreusch et al., Structure analysis of peptide deformylases fromStreptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritimaandPseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase. J Mol Biol. Jul. 4, 2003;330(2):309-21.
Kroemer, Mitochondria in cancer. Oncogene. Aug. 7, 2006;25(34):4630-2.
Kuntz et al., A geometric approach to macromolecule-ligand interactions. J Mol Biol. Oct. 25, 1982;161(2):269-88.
Lazennec et al., Formate dehydrogenase-coupled spectrophotometric assay of peptide deformylase. Anal Biochem. Jan. 1, 1997;244(1):180-2.
Leeds et al., Peptide deformylase as an antibacterial target: a critical assessment. Curr Opin Pharmacol. Oct. 2006;6(5):445-52. Epub Aug. 9, 2006.
Liao et al., Identification and initial characterization of translational initiation factor 2 from bovine mitochondria. J Biol Chem. Aug. 15, 1990;265(23):13618-22.
Lofland et al., in vitro antibacterial activity of the peptide deformylase inhibitor BB-83698. J Antimicrob Chemother. Apr. 2004;53(4):664-8. Epub Feb. 18, 2004.
Martin, 3D database searching in drug design. J Med Chem. Jun. 12, 1992;35(12):2145-54.
Mazel et al., Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBO J. Feb. 15, 1994;13(4):914-23.
Meinnel et al., A new subclass of the zinc metalloproteases superfamily revealed by the solution structure of peptide deformylase. J Mol Biol. Sep. 27, 1996;2
Escobar-Alvarez Sindy Noemi
Goldgur Yehuda
Li Yueming
Scheinberg David A.
Baker C. Hunter
Sloan-Kettering Institute for Cancer Research
Steadman David J
Wolf Greenfield & Sacks P.C.
LandOfFree
Method of inhibitor design and identification using a 3-D... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibitor design and identification using a 3-D..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibitor design and identification using a 3-D... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4172407